Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Toxicology ; 334: 81-93, 2015 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-26066519

RESUMEN

Rates of obesity and diabetes mellitus of Arctic populations are increasing due to multiple reasons including a departure from traditional lifestyles and alcohol consumption patterns. These populations are also exposed to a variety of anthropogenic contaminants through consumption of contaminated country foods. We have previously shown that a Northern contaminant mixture (NCM), containing 22 organic and inorganic contaminants found in the blood of Canadian Arctic populations, induces endothelial cell dysfunction and exacerbates development of non-alcoholic fatty liver disease in experimental models. In order to determine if these contaminants affect pancreas function and physiology and if obesity and alcohol can influence contaminant toxicity and the development of diabetes, lean and obese JCR rats were orally treated with NCM at 0 (vehicle), 1.6 or 16mg/kg BW for four weeks in the presence or absence of 10% (v/v) alcohol. NCM treatment altered islet morphology, increased iron deposit in pancreas, and reduced circulating and pancreatic insulin levels and circulating glucagon levels as a result of direct islet injury with ß and α cell loss with or without exposure to alcohol. Studies conducted with cultured mouse insulin-secreting (MIN6) ß cells further demonstrated that NCM inhibited insulin release and induced cell death through oxidative stress and mitochondrial dysfunction. 2,3,4,6-Tetrabromophenol, a minor component of the NCM, alone also inhibited insulin release from MIN6 cells after 10min of exposure. These results suggest that Northern contaminants may contribute to pancreatic dysfunction, and possibly development of diabetes, in some of the highly exposed Arctic populations. The implications and relevance of these findings to Northern populations remains to be confirmed through epidemiological studies.


Asunto(s)
Mezclas Complejas/toxicidad , Diabetes Mellitus/inducido químicamente , Contaminantes Ambientales/toxicidad , Insulina/metabolismo , Insulinoma/metabolismo , Islotes Pancreáticos/efectos de los fármacos , Obesidad/complicaciones , Neoplasias Pancreáticas/metabolismo , Delgadez/complicaciones , Consumo de Bebidas Alcohólicas/efectos adversos , Animales , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Diabetes Mellitus/sangre , Diabetes Mellitus/patología , Diabetes Mellitus/fisiopatología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Glucagón/sangre , Insulina/sangre , Secreción de Insulina , Islotes Pancreáticos/metabolismo , Islotes Pancreáticos/fisiopatología , Masculino , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Mitocondrias/patología , Obesidad/sangre , Obesidad/patología , Obesidad/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Ratas , Medición de Riesgo , Delgadez/sangre , Delgadez/patología , Delgadez/fisiopatología
2.
PLoS One ; 9(9): e106832, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25222487

RESUMEN

Non-alcoholic fatty liver disease (NAFLD), defined by the American Liver Society as the buildup of extra fat in liver cells that is not caused by alcohol, is the most common liver disease in North America. Obesity and type 2 diabetes are viewed as the major causes of NAFLD. Environmental contaminants have also been implicated in the development of NAFLD. Northern populations are exposed to a myriad of persistent organic pollutants including polychlorinated biphenyls, organochlorine pesticides, flame retardants, and toxic metals, while also affected by higher rates of obesity and alcohol abuse compared to the rest of Canada. In this study, we examined the impact of a mixture of 22 contaminants detected in Inuit blood on the development and progression of NAFLD in obese JCR rats with or without co-exposure to 10% ethanol. Hepatosteatosis was found in obese rat liver, which was worsened by exposure to 10% ethanol. NCM treatment increased the number of macrovesicular lipid droplets, total lipid contents, portion of mono- and polyunsaturated fatty acids in the liver. This was complemented by an increase in hepatic total cholesterol and cholesterol ester levels which was associated with changes in the expression of genes and proteins involved in lipid metabolism and transport. In addition, NCM treatment increased cytochrome P450 2E1 protein expression and decreased ubiquinone pool, and mitochondrial ATP synthase subunit ATP5A and Complex IV activity. Despite the changes in mitochondrial physiology, hepatic ATP levels were maintained high in NCM-treated versus control rats. This was due to a decrease in ATP utilization and an increase in creatine kinase activity. Collectively, our results suggest that NCM treatment decreases hepatic cholesterol export, possibly also increases cholesterol uptake from circulation, and promotes lipid accumulation and alters ATP homeostasis which exacerbates the existing hepatic steatosis in genetically obese JCR rats with or without co-exposure to ethanol.


Asunto(s)
Contaminantes Ambientales/efectos adversos , Hígado Graso/inducido químicamente , Metabolismo de los Lípidos/efectos de los fármacos , Adenosina Trifosfato/metabolismo , Animales , Colesterol/metabolismo , Exposición a Riesgos Ambientales , Etanol/toxicidad , Homeostasis/efectos de los fármacos , Humanos , Inuk , Hígado/efectos de los fármacos , Hígado/metabolismo , Ratas Endogámicas
3.
Toxicology ; 313(2-3): 103-12, 2013 Nov 16.
Artículo en Inglés | MEDLINE | ID: mdl-23384447

RESUMEN

It has been reported that Northern populations are exposed to mixtures of various environmental contaminants unique to the Arctic (Northern contaminant mixtures - NCM) at a large range of concentrations, depending on their geological location, age, lifestyle and dietary habits. To determine if these contaminants may contribute to a cardiovascular health risk, especially when combined with a high fat and sugar diet and ethanol exposure, we treated human coronary artery endothelial cells (HCAEC) with two mixtures of 4 organic (NCM1) or 22 organic and inorganic (NCM2) chemicals detected in Northerners' blood during 2004-2005 in the presence or absence of low-density lipoprotein (1.5mg/ml), very-low-density lipoprotein (1.0mg/ml) and glucose (10mmol/L) (LVG), and in the absence or presence of 0.1% ethanol. After 24h of exposure, cell morphology and markers of cytotoxicity and endothelial function were examined. NCM1 treatment did not affect cell viability, but increased cell size, disrupted cell membrane integrity, and decreased cell density, uptake of small peptides, release of endothelin-1 (ET-1) and plasminogen activator inhibitor (PAI), while causing no changes in endothelial nitric oxide synthase (eNOS) protein expression and nitric oxide (NO) release. In contrast, NCM2 decreased cell viability, total protein yield, uptake of small peptides, eNOS protein expression, and NO release and caused membrane damage, but caused no changes in the secretion of ET-1, prostacyclin and PAI. The presence of LVG and/or alcohol did or did not influence the effects of NCM1 or NCM2 depending on the endpoint and the mixture examined. These results suggested that the effects of one or one group of contaminants may be altered by the presence of other contaminants, and that with or without the interaction of high fat and sugar diet and/or ethanol exposure, NCMs at the concentrations used caused endothelial dysfunction in vitro. It remains to be investigated if these effects of NCMs also occur in vivo.


Asunto(s)
Mezclas Complejas/toxicidad , Vasos Coronarios/efectos de los fármacos , Dieta Alta en Grasa/efectos adversos , Sacarosa en la Dieta/efectos adversos , Células Endoteliales/efectos de los fármacos , Contaminantes Ambientales/toxicidad , Etanol/efectos adversos , Regiones Árticas , Biomarcadores/metabolismo , Glucemia/metabolismo , Técnicas de Cultivo de Célula , Línea Celular , Supervivencia Celular/efectos de los fármacos , Mezclas Complejas/sangre , Vasos Coronarios/metabolismo , Vasos Coronarios/patología , Células Endoteliales/metabolismo , Células Endoteliales/patología , Exposición a Riesgos Ambientales , Contaminantes Ambientales/sangre , Humanos , Lipoproteínas LDL/sangre , Lipoproteínas VLDL/sangre , Modelos Biológicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...